Congratulations Alejandro!

César Carnicer, Alejandro Pascual and Louisa de Arriba

The General Manager of Laboratorios Syva, César Carnicer, and the Director of Biological R&D, Mª Luisa de Arriba, awarded the 24th Syva Award for thebest Doctoral Thesis in Animal Healthon Monday 26 April.

The winner, Dr. Alejandro Pascual Iglesias, visited our facilities to receive the award for his research work “Porcine epidemic diarrhoea virus: pathogenesis and protection”presented under the direction of Dr. Luis Enjuanes and Dr. Sonia Zúñiga.

During Alejandro’s visit, we collected his impressions and advice for young people who want to get started in animal health research and we conducted an interview with our general manager César Carnicer.

We will tell you more about it in the next few days!

In the meantime, if you haven’t yet read our interview with Alejandro and his directors, you can do so here.

You may also be interested in

30 August, 2023

New tool for controlling erysipelas and PPV: Syvac® Ery Parvo

Because every farm is unique, it needs individualised protocols for swine erysipela and PPV control. Failing to control erysipelas and PPV throughout a sow's life can lead to a host of problems that are difficult to control and have a direct impact on production.

Read more

19 July, 2023

Interview with Inés Ruedas, winner of the Syva Award 2023 – Tierras Porcino

We could not miss this excellent interview, conducted by Interempresas for Tierras Porcino, which recently interviewed our Syva 2022 award winner, Inés Ruedas Torres, about her thesis and the numerous challenges that the pig sector faces in the fight against PRRSV. In her interview, Inés speaks about the new advances in the fight against this disease, but also about the...

Read more

2 March, 2023

SYVA announces its partnership with the biotech SMIVET for the development of SDA [SDA]

León - Technology Park – Spain, March 2, 2023 - SYVA and SMIVET signed a collaboration agreement that allow both companies to develop therapeutic solutions based on Single Domain Antibodies (SDA). With this agreement, Syva expresses its willingness to invest in new biotechnologies with the objective to continue to grow and improve its attractiveness by researching, developing, and producing...

Read more